GIFT-CF3

ABSTRACT: Effects of Elexacaftor/Tezacaftor/Ivacaftor therapy on the gut microbiome and clinical outcomes in people with cystic fibrosis

PROVIDER: PRJEB61286 | ENA |

REPOSITORIES: ENA